Margin pinch amid solid international; domestic slipping

Consolidated revenue ₹515 Cr vs prior ~₹455 Cr; 13% growth confirmed. But standalone India only 8%.

PAT ₹17 Cr vs prior ~₹10.8 Cr = 57.8% growth. Entirely driven by consolidated (US + UK + Germany). Standalone PAT only 7%.

Domestic standalone only 7% growth; export 9%. Consolidated 13% includes international. CFO acknowledged 'almost touched double digit' but fell short.

Standalone EBITDA down 17% YoY; gross margin fell from 47% to 43% (400 bps). Raw material + LPG cost spikes confirmed. Price increases implemented but time lag acknowledged.

Management concluded 'worst is behind us' but with heavy caveat: 'tomorrow brings another day, world changes fast, difficult to predict.' Cautious phrasing.

Prior call: strong domestic gains. Q1: standalone 8% vs 7.4% market forecast. CFO 'almost touched double digit' – miss vs target.

Standalone EBITDA down 17% YoY; gross margin fell 400 bps (47% → 43%). Raw material + LPG spike worse than expected. Pricing lag unresolved.

US double-digit growth; Monocon/Sheffield double-digit combined. UK sentiment improved (British Steel public ownership de-risks longevity).

Prior: Monocon under pressure. Q1: losses shrunk Q-o-Q (no exact number divulged but CFO confirmed narrowing). On track to breakeven by FY27 end.

Prior: 'double-digit growth', 'strong domestic', 'international recovery'. Q1: same aspirations reaffirmed but domestic (7%) and EBITDA (7.7%) fell short. No numeric upward revision.

Americas driving growth with robust margins. Individual company details withheld; segment results published separately. Momentum expected to maintain across U.K., Europe, Americas, Germany; focus on profitability turnarounds.

Phase 1 ramming mass now in production at Vizag facility; marketing trials ongoing. Other products in joint visits and trials with customers; will take time for full market maturation and accreditation.

Base effect (prior year smaller base). Consol approach shows better—export strong. EBITDA dip due to raw material and LPG cost spike, not competitive pricing. Price increases implemented; insufficient to offset in Q1.

Europe = Monocon U.K. + Sheffield. Both individually good. Sheffield suffered due to British Steel blast furnace shutdown (timing, not structural loss). Monocon U.K. moving to breakeven. Q2 expected normal when British Steel restarts.

Price increases on contract-by-contract basis, not evenly distributed. Temporary increases tied to input cost shocks (geopolitical). No additional margin uplift expected; aim to compensate only.

Targeting double-digit EBITDA margin (consol). Dependent on geopolitical and overseas demand. Will be back on this.

Unlikely. Old dues unsecured; administrators will handle post-new-buyer. Upside: can resell products and re-establish service team if restart succeeds.

Iron/steel refractory products; foundry industry entry planned. Geographies: U.K., China; recently opened Australia and Saudi Arabia offices. Strong customer feedback from Mexico and U.S.A. for market expansion.

Monocon U.K. back to black will lift overall EBITDA. U.S. already double-digit margin contributor. Each subsidiary being worked to restore past margins.

Not divulging exact loss number. But losses narrowed Q-o-Q for Monocon U.K.

Correction: R&D spend ~₹20 Cr. Facility developing new materials (foundry); special tundish SEN for thin slab caster (U.S. market, showing strong results); recycling initiatives; team augmentation. R&D supporting global sales.

JV applied to Government of India; advised to change location and reapply. Awaiting approval. On hold. Gujarat land acquisition done; some marketing spend. Cement industry import substitution focus.

No specific current capacity number. Mag carbon brick + casting flux new lines can add ₹150–200 Cr at peak capacity for those two products alone.

Aspiration carried forward; Q1 only 7%. CFO said 'almost touched double digit'. Requires Q2–Q4 acceleration to +12% or higher.

U.S. strong; Monocon U.K. and Sheffield on recovery path; geographic expansion (Saudi, Australia) beginning.

New lines not yet at peak; timeline not specified. Provisional upside target.

Current: 7.7% (Q1 FY27). Prior target cited; not formally changed. Dependent on Monocon U.K. breakeven and cost absorption.

No margin uplift in Q1 due to lag. CFO: 'temporary price increases based on input costs; no additional margin expected; aim to compensate only.'

Incremental capex spend not quantified. Timeline for these new lines not specified on call.

Capex timing indefinite. Land acquisition in Gujarat already done (spend undisclosed).

R&D spend ~₹20 Cr; facility works ongoing. Delivering tangible wins (U.S. tundish market, foundry entry for Monocon).

Raw material (geopolitical + supply chain) and LPG costs up sharply. Standalone EBITDA down 17% YoY despite price increases. Pricing actions take 1–2 quarters to flow through.

Standalone domestic revenue only +7% YoY (target: double-digit). CFO acknowledged 'almost touched double digit' but fell short. Market share claims not directly supported by growth rate.

Monocon U.K. and Sheffield ramping but losses still material. Hofmann Ceramic targeting breakeven by FY27 end (aggressive). Exposure to British Steel timing and other customer volatility.

Sheffield revenue collapsed Q1 due to British Steel blast furnace outage (timing, not structural). Restart expected Q2 but timing uncertain. Liberty Steel (Specialty Steel) restart Nov–Dec 2026 not guaranteed.

Geopolitical uncertainties driving raw material cost spikes. Ocean freight surge (UK, China operations impacted). Supply chain disruptions ongoing.

Chinese JV (cement industry import substitution) on hold awaiting GoI approval after location change request. Land acquisition in Gujarat done; timing unknown.